RFK Jr. says the COVID-19 vaccine is no longer on the CDC's recommended schedule for healthy kids and pregnant women, though ...

Novavax, Inc. (“Novavax”) announced that FDA approved its Biologics License Application (“BLA”) for Nuvaxovid™ for active ...

HHS Secretary Robert F. Kennedy Jr. says the CDC no longer recommends COVID-19 vaccines for healthy pregnant women & children ...

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

Last week saw Novavax receive full approval from the US Food and Drug Administration (FDA) for its COVID-19 vaccine, but with ...

新冠疫情的持续影响，让全球各国对疫苗研发的重视达到了前所未有的高度。然而，近期美国对新冠疫苗研发的资金支持骤然削减，令众多生物科技公司陷入了困境，面临资金断裂的风险。更令人感到担忧的是，这种现象不仅影响了企业的生存，更可能对未来的公共卫生安全造成深远影响。

As the World Health Organization initiates a new agreement for coordinating global responses to future pandemics, the future of vaccine development in the U.S. faces growing challenges, including ...

The FDA expects that randomized, controlled trial data on clinical outcomes will be needed before COVID-19 vaccines can be approved for patients who are 6 months to 64 years of age and do not have ...

Kepler Capital analyst Richard Withagen maintained a Buy rating on Diageo (DGEAF – Research Report) on May 23 and set a price target of p2,700.00. The company’s shares closed ...

France has detected four cases of the new COVID-19 variant NB.1.8.1 for the first time, Anadolu Ajansi reported. Four cases ...

“If the FDA does not approve a vaccine for a population, then the vaccine will likely not be covered by insurers for that ...

BofA analyst Alec Stranahan reiterated a Hold rating on Novavax, Inc. (NASDAQ:NVAX) stock, setting a price target of $10. The ...